SJ

Sanjaykumar Jitendrabhai Jha

Active Director Director DIN 01525404
DIN 01525404 First appointment May 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 15 active board seats
Past companies 6 historical roles
Total affiliations 21 Since May 2007
Shareholding value •••• Premium profile

About Sanjaykumar Jitendrabhai Jha

Data last updated:

Sanjaykumar Jitendrabhai Jha is a Director at Santis Pharmaceuticals Private Limited (since 2010), Director at Salvavita Pharmaceuticals Private Limited (since 2020) and Director at Cuidado Medico Private Limited (since 2009), and holds 12 more current directorships. The companies operate in Pharma, Trading and Sports. The 11 current companies with reported revenue have a combined latest revenue of ₹28.72 Cr; the largest is Santis Pharmaceuticals Private Limited at ₹13.90 Cr (FY 2021). Earlier, Sanjaykumar Jitendrabhai Jha was a Director at Evinos Pharmaceuticals Private Limited (2022–2023) and Director at Ratnatris Pharmaceuticals Private Limited (2019–2021) and 4 more.

DIN 01525404
Primary Designation Director
Industry Pharma
First Appointment 11 May 2007
Oldest Company Age 19 yrs
Largest company Santis Pharmaceuticals Private Limited · ₹13.90 Cr (FY 2021)
Combined revenue ₹28.72 Cr across 11 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Apr 20102010₹13.90 Cr (FY 2021)Active
Director25 Dec 20202020₹9.64 Cr (FY 2024)Active
Cuidado Medico Private Limited U24230GJ2009PTC055921
Director20 Jan 20092009₹3.54 Cr (FY 2025)Active
Zorway Exim Private Limited U52399GJ2010PTC059829
Director11 Mar 20102010₹77.3 Lakh (FY 2025)Active
Synergy Pharmasource Private Limited U24239GJ2011PTC063969
Director09 Feb 20112011₹54.9 Lakh (FY 2024)Active
Emzor Exports Private Limited U51909GJ2007PTC050786
Director11 May 20072007₹23.6 Lakh (FY 2017)Active
Pharmacy Next Door Private Limited U51909GJ2019PTC109484
Director09 Aug 20192019₹5.5 Lakh (FY 2021)Active
Avensis Exim Private Limited U51109GJ2009PTC056485
Director31 Mar 20092009₹1.5 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Nov 20222022₹2.30 Cr (FY 2025)Active
Director31 Jan 20192005₹142 Cr (FY 2025)Active
Nosak Healthcare Private Limited U24230GJ2009PTC058623
Director18 Nov 20092009Strike Off
Director04 Oct 20182018Strike Off
Director28 Mar 20122012Strike Off
Onnext Healthcare Private Limited U74999GJ2017PTC096355
Director17 Mar 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Santis Pharmaceuticals Private Limited
Cuidado Medico Private Limited
Nosak Healthcare Private Limited
Avensis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjaykumar Jitendrabhai Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjaykumar Jitendrabhai Jha

Sanjaykumar Jitendrabhai Jha currently holds 15 directorships: Santis Pharmaceuticals Private Limited (Director, since 19 Apr 2010, revenue ₹13.90 Cr (FY 2021)); Salvavita Pharmaceuticals Private Limited (Director, since 25 Dec 2020, revenue ₹9.64 Cr (FY 2024)); Cuidado Medico Private Limited (Director, since 20 Jan 2009, revenue ₹3.54 Cr (FY 2025)); Zorway Exim Private Limited (Director, since 11 Mar 2010, revenue ₹77.3 Lakh (FY 2025)); Synergy Pharmasource Private Limited (Director, since 09 Feb 2011, revenue ₹54.9 Lakh (FY 2024)); and 10 more.

Sanjaykumar Jitendrabhai Jha was first appointed on 11 May 2007 as Director at Emzor Exports Private Limited. The most recent appointment on record is 08 Oct 2025 at Injexa Lifesciences Private Limited.

The 11 current companies of Sanjaykumar Jitendrabhai Jha that report revenue have a combined latest revenue of ₹28.72 Cr: Santis Pharmaceuticals Private Limited ₹13.90 Cr (FY 2021); Salvavita Pharmaceuticals Private Limited ₹9.64 Cr (FY 2024); Cuidado Medico Private Limited ₹3.54 Cr (FY 2025); Zorway Exim Private Limited ₹77.3 Lakh (FY 2025); Synergy Pharmasource Private Limited ₹54.9 Lakh (FY 2024); and 6 more.

Sanjaykumar Jitendrabhai Jha held 6 earlier board appointments: Evinos Pharmaceuticals Private Limited (Director, 18 Nov 2022 to 03 Jan 2023); Ratnatris Pharmaceuticals Private Limited (Director, 31 Jan 2019 to 10 Jul 2021); Nosak Healthcare Private Limited (Director, from 18 Nov 2009); Sukarnov Pharmaceuticals Private Limited (Director, from 04 Oct 2018); Miral Pharmaceuticals Private Limited (Director, from 28 Mar 2012); and 1 more.

The current boards of Sanjaykumar Jitendrabhai Jha's companies include Kosha Sanjay Jha (Santis Pharmaceuticals Private Limited), Poonam Samir Desai (Salvavita Pharmaceuticals Private Limited), Jagdishbhai Bhagwatbhai Desai (Cuidado Medico Private Limited), Kartik Nalinbhai Raval (Cuidado Medico Private Limited), Ghanshyam Jitendrabhai Jha (Zorway Exim Private Limited), Hetal Kaushal Shah (Synergy Pharmasource Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available